| AstraZeneca AG - Trixeo Aerosphere 160/14.4/5 μg, Druckgasinhalation, Suspension | | 68388 | | 02 | | Trixeo Aerosphere 160/14.4/5 μg | | Druckgasinhalation, Suspension | | R03AL11 | | Formoterol, Glycopyrronium Bromide and Budesonide | | 09.10.2026 | | |
| | Composition | | budesonidum 160 µg, glycopyrronii bromidum 18 µg corresp. glycopyrronium 14.4 µg, formoteroli fumaras dihydricus 5 µg, 1,2-distearoyl-sn-glycero-3-phosphocholinum, calcii chloridum dihydricum, norfluranum, ad suspensionem pro dosi. | | Packungsbestandteile | | | | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 004 | 120 | | | B | | Oui | | 005 | 3 x 120 | | | B | | Oui |
|
|
